It is certainly the case that there have been issues, but there is nowhere near the scale of crisis that we're facing now. Now, nobody is saying that our current system for regulating medicines is perfect. The health Minister regularly has some of us on our feet in this Chamber asking him to make medicines available that haven't gone through the NICE process, but the reality is that the NICE process is there to protect people, and, if we do the deal that Donald Trump wants—and it's perfectly clear that that's what he wants—if we do the deal, our NHS will have to be exposed to these kinds of US practices, because if they—[Interruption.] If Janet Finch-Saunders would like to make an intervention, I'd be delighted to hear from her, as always. Otherwise, perhaps she could allow me to continue.